'Patient groups' presentation slideshows

Robert E. Connors, FACHE, PMP MS in Information Systems Technology MHA, Healthcare Administration

765 views • 61 slides

Welcom e

Welcom e. Aims of the day. Offer opportunities for development, networking and support so members feel they can have the greatest influence Provide members with an opportunity to give feedback Ideas about how we can improve the involvement of members as partners in the future.

697 views • 42 slides

Fluid resuscitation of trauma patients: how fast is the optimal rate?

Fluid resuscitation of trauma patients: how fast is the optimal rate?. Yasuaki Mizushima MD*, Hideo Tohira MD, Yasumitsu Mizobata MD, Tetsuya Matsuoka MD, Junichiro Yokota MD Osaka Prefectural Senshu Critical Care Medical Center, Osaka, 598-0048, Japan

909 views • 35 slides

ANNUAL REVIEW ACTIONS 2007/08 Andrew Robertson OBE LLB Chairman NHS Greater Glasgow & Clyde

ANNUAL REVIEW ACTIONS 2007/08 Andrew Robertson OBE LLB Chairman NHS Greater Glasgow & Clyde. General Overview of all Actions. General Overview of all Actions. Reducing Alcohol Misuse. Development and implementation of Joint Alcohol Policies

495 views • 33 slides

?? BMJ ???????????? -- ???????????????????? ?? BMJ Group hwang@bmjgroup

504 views • 32 slides

Is Fresh Blood Really Necessary: What is the Latest?

Is Fresh Blood Really Necessary: What is the Latest?. Sarah Harm, MD Department of Pathology University of Pittsburgh Medical Center Institute for Transfusion Medicine. en.wikitravel.org. Retrospective or observational studies. Retrospective Studies. Positives Easier to get IRB approval

415 views • 31 slides

ASENT 13 th Annual Meeting Outcome Measures to Support Labeling Claims: What is new FDA Guidance?

ASENT 13 th Annual Meeting Outcome Measures to Support Labeling Claims: What is new FDA Guidance?. Elektra J. Papadopoulos, M.D., M.P.H. Study Endpoints and Labeling Development CDER/FDA February 24, 2011. Disclosures. No conflicts. Presentation Outline. FDA review of rating scales

369 views • 25 slides

Results from >2,300 Patients in The SOURCE TAVI Registry: Changes in Patient Populations with time.

642 views • 23 slides

FACET - European Journal of Cancer Care July 2006

FACET - European Journal of Cancer Care July 2006. Palliative care for intractable breathlessness in cancer Booth, S. 1. Managing breathlessness Breathlessness is such a common problem that it requires all of us to be able to begin to start treating it. Slide One.

384 views • 23 slides

Pulmonary Artery Catheter

Pulmonary Artery Catheter. Marie Sankaran Raval M.D. Boston Medical Center Department of Anesthesiology. Pulmonary Artery Catheter. What is a pulmonary artery catheter? Pulmonary Artery Catheterization Indications Hemodynamic Parameters Oxygen Transport Parameters Benefits

3.13k views • 22 slides

Task shifting & HRH Crisis : field experience and current thinking within MSF

342 views • 22 slides

Imaging of laser-excited skin autofluorescence bleaching rates.

Imaging of laser-excited skin autofluorescence bleaching rates. Kristine Rozniece, Ilona Hartmane Clinical Center of Skin and ST Diseases, Riga, Latvia Janis Lesinsh, Janis Spigulis, ASI, LU, Riga, Latvia European Social Fund

382 views • 19 slides

Hospitals

Hospitals. HAS 4320. Revenue. Philanthropy and grants Global budgets Charges Per diem. Revenue. Cost reimbursement Per Case Capitation Managed care contracts. Funds Out. Payroll = 54% Professional fees = 4% Supplies and other = 33% Capital depreciation and interest = 9%.

236 views • 19 slides

Medicines Use Review [MUR]

Medicines Use Review [MUR]. Liz Stafford LPC/PCT liaison. Outline. Context Understanding potential benefits of MURs Identifying potential barriers & how to overcome them Good practice examples Key Success Factors. Context. NHS Community Pharmacy contract 2004.

489 views • 18 slides

Dr. Henk A.J. Mulder Science Shops, University of Groningen, The Netherlands www.scienceshops.org

421 views • 16 slides

320 views • 14 slides

M&E and Advocacy

270 views • 12 slides

European Patient Association Network

European Patient Association Network. Presented by Dr Judith Wardle Director, Continence Foundation UK. History. March 2004 meeting of patient groups arranged by Pfizer to: Inform about current trends in diagnosis & treatment of OAB

366 views • 10 slides

Pharmaceutical Needs Assessment

Pharmaceutical Needs Assessment. 1. What is a PNA? . PNA document will provide a complete picture of the local population and how they differ in terms of their health needs and requirements PNA will assist in improving health, well being and reduce inequalities

522 views • 8 slides

mentoring the motivated.

mentoring the motivated. Strategic Communication in the German Social Health Insurance System Percivil M. Carrera, LLM, PhD. Source: Busse and Riesberg 2006. The Federal Joint Committee.

155 views • 6 slides